The British Business Bank has made a second investment under its new co-investment strategy as part of its £350m Regional Angels Programme into Portal Biotech, a developer of a real-time, single-molecule protein sequencing technology. The company has raised £27 million ($37m) in an oversubscribed round led by Earlybird and NATO Innovation Fund.